Repare Therapeutics Inc (RPTX)
3.57
+0.04
(+1.13%)
USD |
NASDAQ |
May 17, 16:00
3.57
0.00 (0.00%)
Pre-Market: 20:00
Repare Therapeutics Price: 3.57 for May 17, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 17, 2024 | 3.56 | 3.66 | 3.445 | 3.55 | 218969.0 |
| May 16, 2024 | 3.57 | 3.619 | 3.47 | 3.53 | 114122.0 |
| May 15, 2024 | 3.75 | 3.80 | 3.50 | 3.57 | 182946.0 |
| May 14, 2024 | 3.71 | 3.88 | 3.69 | 3.69 | 254884.0 |
| May 13, 2024 | 3.56 | 3.89 | 3.55 | 3.70 | 301631.0 |
| May 10, 2024 | 3.66 | 3.745 | 3.50 | 3.50 | 289644.0 |
| May 09, 2024 | 3.75 | 3.949 | 3.52 | 3.64 | 724885.0 |
| May 08, 2024 | 3.88 | 3.96 | 3.560 | 3.79 | 4.589M |
| May 07, 2024 | 3.39 | 3.46 | 3.26 | 3.28 | 73158.00 |
| May 06, 2024 | 3.45 | 3.59 | 3.39 | 3.40 | 118440.0 |
| May 03, 2024 | 3.48 | 3.74 | 3.445 | 3.45 | 173798.0 |
| May 02, 2024 | 3.33 | 3.57 | 3.30 | 3.35 | 131797.0 |
| May 01, 2024 | 3.09 | 3.50 | 3.09 | 3.30 | 203900.0 |
| Apr 30, 2024 | 3.22 | 3.22 | 3.06 | 3.10 | 166417.0 |
| Apr 29, 2024 | 3.26 | 3.30 | 3.15 | 3.20 | 102322.0 |
| Apr 26, 2024 | 3.18 | 3.24 | 3.11 | 3.20 | 71408.00 |
| Apr 25, 2024 | 3.26 | 3.26 | 3.114 | 3.15 | 82157.00 |
| Apr 24, 2024 | 3.37 | 3.420 | 3.26 | 3.30 | 73015.00 |
| Apr 23, 2024 | 3.24 | 3.43 | 3.24 | 3.36 | 175626.0 |
| Apr 22, 2024 | 3.16 | 3.40 | 3.09 | 3.26 | 109321.0 |
| Apr 19, 2024 | 3.02 | 3.28 | 2.98 | 3.15 | 219182.0 |
| Apr 18, 2024 | 3.19 | 3.25 | 3.00 | 3.02 | 140289.0 |
| Apr 17, 2024 | 3.37 | 3.37 | 3.16 | 3.21 | 79291.00 |
| Apr 16, 2024 | 3.47 | 3.47 | 3.24 | 3.34 | 85215.00 |
| Apr 15, 2024 | 3.65 | 3.71 | 3.35 | 3.47 | 89849.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.02
Minimum
Apr 18 2024
44.46
Maximum
Jan 07 2021
18.13
Average
14.25
Median
Dec 27 2022
Price Benchmarks
| Acasti Pharma Inc | 2.69 |
| Aurinia Pharmaceuticals Inc | 5.76 |
| Edesa Biotech Inc | 4.65 |
| Lexaria Bioscience Corp | 3.15 |
| InMed Pharmaceuticals Inc | 0.2949 |
Price Related Metrics
| PS Ratio | 1.545 |
| PEG Ratio | -0.0787 |
| Price to Book Value | 0.6496 |
| Earnings Yield | -30.99% |
| Market Cap | 150.68M |
| PEGY Ratio | -0.0787 |